Answer
Pemigatinib inhibits fibroblast growth factor receptors FGFR1, FGFR2 and FGFR3.
Sources for this answer
- Pemazyre 4.5 mg - tabletsIncyte Biosciences UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 6Document updated
Sources checked